Preclinical studies demonstrate elevated intracellular NAD+ levels following NNMT inhibition, suggesting a role in metabolic energy regulation
Manufacturing of this sterile product demands proper aseptic environment, well-functioned machines and compliance to good manufacturing practices to attain a high quality product
Frequently asked questions Our team of experts has the answers you're looking for
Gastrointestinal symptoms: Some peptides, especially GLP-1 receptor agonists such as semaglutide or tirzepatide, can slow digestion, which may lead to nausea, vomiting, diarrhea, or constipation
That can mean steadier energy and better metabolic support, especially if your levels are low
No question is too small to ask